ACHROMYCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Achromycin, and what generic alternatives are available?
Achromycin is a drug marketed by Lederle, Storz, and Avet. and is included in seven NDAs.
The generic ingredient in ACHROMYCIN is hydrocortisone; tetracycline hydrochloride. There are sixty-seven drug master file entries for this compound. Additional details are available on the hydrocortisone; tetracycline hydrochloride profile page.
Summary for ACHROMYCIN
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 6,384 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ACHROMYCIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ACHROMYCIN
US Patents and Regulatory Information for ACHROMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lederle | ACHROMYCIN | procaine hydrochloride; tetracycline hydrochloride | INJECTABLE;INJECTION | 050276-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Storz | ACHROMYCIN | tetracycline hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 050268-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Lederle | ACHROMYCIN | tetracycline hydrochloride | INJECTABLE;INJECTION | 050273-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Avet | ACHROMYCIN V | tetracycline hydrochloride | CAPSULE;ORAL | 050278-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
